Plandai Biotechnology, Inc. · OTC:PLPL
Plandai Biotechnology — Investor Presentation (May 2012)
18 slides from Plandai Biotechnology's investor presentation, May 4, 2012
Slide 1: Plandaí Biotechnology Inc.
Plandaí Biotechnology Inc. “Unlocking Nature’s Secrets”™
Slide 2: Safe Harbor, Disclaimer, Copyright and Trademark
• Safe Harbor Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors
Slide 3: The Company
The Company • Plandaí Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials. • Financing provided by $13million loan from the Land Bank of South Africa, secured and funded – May 2012 • Plandaí control has notarial leases on an existing tea estate and other farms tota
Slide 4: What is Phytofare™
What is Phytofare™ • Super Green Tea • Highly Bioavailable (60-80%) extract from live plant materials • Proprietary extract providing up to 8x more absorption of antioxidants than any other product • Main focus – Total catechin extract from green tea • R&D – Carotenoids from tomatoes/Bio-flavanoids
Slide 5: Benefits
Benefits • Anti-oxidative and anti-aging effects • Immune system enhancing effects • Anti-microbial effects and cold prevention • Controlling high blood sugar levels • Controlling high blood pressure • Controlling cholesterol • Weight management
Slide 6: Malaria
Malaria Malaria vaccines are formulated to eliminate the mosquito parasite after it has entered the red blood cells. Green tea extracts has been shown to: • Contain the mosquito parasite transporter before it enters the red blood cells Furthermore our extract has: • Antioxidants naturally extracted
Slide 7: Subsidiaries (% owned)
Subsidiaries (% owned) • Dunn Roman Holdings – Africa: Holding company (81% owned by Plandaí) • Breakwood Trading 22 (Pty) Ltd (74% owned by Dunn Roman) • Green Gold Biotechnology (Pty) Ltd (74% owned by Dunn Roman)
Slide 8: Corporate Structure
Corporate Structure Breakwood Trading 22 (Pty) Plandaí Dunn Roman Ltd Biotechnology Holdings - Africa Inc. (Pty) Ltd Green Gold Biotecnologies (Pty) Ltd
Slide 9: Dunn Roman Holdings (Pty) Ltd
Dunn Roman Holdings (Pty) Ltd • Licensee in Africa for the proprietary processing technology • Holder of the notarial leases (49 years renewable) – 8500 Acres ( existing Tea/Timber/Avocado) • Majority shareholder in both subsidiaries
Slide 10: Breakwood Trading 22 (Pty) Ltd
Breakwood Trading 22 (Pty) Ltd • Farming arm of the holding company • Approx. 2500 acres of land earmarked for tea • Job creation for up to 500 employees • Opportunities for community up-liftment through training and education • Proprietary tea farming technology
Slide 11: Green Gold Biotechnology (Pty) Ltd
Green Gold Biotechnology (Pty) Ltd • Proprietary processing and extraction technology • First of its kind in the world • HACCP certified • MCC certified
Slide 12: Business Model
Business Model Green Gold Biotechnologies (Pty) • Farms the tea Ltd • Sells the extract • Delivers the fresh • Creates the worldwide tea leaf to the extract from the processing facility fresh green tea leaf Breakwood Trading 22 Plandaí Biotechnology (Pty) Ltd Inc.
Slide 13: Road Map 2012-2013
Road Map 2012-2013 ROAD MAP 2012-2013 MAY ’12 JUNE’12 Q3 Q1 ‘13 Q2 ‘13 Q4 Commercial Rejuvenation Validation of Processing project of grade extract Plandaí total Extract and extraction Senteeko available for $13million catechin available for plant commences wholesale to loan executed extract market
Slide 14: Management Team
Management Team • Roger Duffield-President & CEO Roger Duffield has a significant background in the development and management of start-ups, private and public companies, especially in the United States, Europe and South Africa. He was awarded two honorary Russian doctorates in Natural Sciences from
Slide 15: Scientific Advisory Board
Scientific Advisory Board • Dr Tom Matula – Chairman of the Scientific Board Dr. Matula is a world-renowned scientist and entrepreneur with expertise in medical and industrial applications of ultrasound. Dr. Matula is an author of about 40 peer-reviewed publications, and has several patents in the m
Slide 16: Financial Pro Forma - consolidated
Financial Pro Forma - consolidated Financial Pro-Forma Consolidated In US Dollars Financial Year 2013 Financial Year 2014 Financial Year 2015 Financial Year 2016 Financial Year 2017 TOTAL 120 Tonnes@$400/kg 120 Tonnes@$500/kg 135 Tonnes @ $500/kg 180 Tonnes @ $500/kg 180 Tonnes @ $600/kg 735 Tonnes:
Slide 17: Capitalization
Capitalization • Plandai Biotechnology Inc trades on OTC Bulletin Board: PLPL • PLPL Shares – Outstanding 101,415,300 (as of 12/31/11) – Market Cap 27,382,000 – Avg. Volume 111,000
Slide 18: Address & Contact details
Address & Contact details • Physical 2226 Eastlake Avenue East, Suite 156 Seattle, WA 98102 USA • Email tim@plandaibiotech.com • Telephone 425.466.0212
Plandai Biotechnology — Investor Presentation (May 2012) on 6ix